Hidroxiurea Varifarma
THERAPEUTIC AREA: Oncology / Hematology + Onco-Hematology
ACTIVE PRINCIPLE: Hydroxyurea
PRESENTATION: 500 mg x 100 capsules
INDICATION:
- Chronic Myeloid Leukemia
- Myelofibrosis
- Essential Thrombocythemia
COUNTRIES WHERE IT IS MARKETED:
